Bionano Genomics, Inc. ( BNGO) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Good day, and welcome to the Bionano Third Quarter 2025 Earnings Conference Call. Today's conference is being ...
Following publication of KEYNOTE-689 Phase 3 results confirming the role of perioperative checkpoint inhibition in head and neck cancer, GeoVax announced plans for a Phase 2 trial (AdPNP-203) ...
A new technology may allow patients to recover vision for conditions that were previously thought irreversible ...
A multi-disciplinary approach was employed, using a combination of multiomic techniques, including single-cell RNA-sequencing ...
Genetic Testing Market - Test Types, Technologies and Distribution Channels" has been added to ResearchAndMarkets.com's offering. The global DTC genetic testing market is heading for significant ...